Journal List > Ann Dermatol > v.27(5) > 1046078

Han, Lim, Park, and Rhie: Congenital Dermatofibrosarcoma Protuberans: A Case Report and Literature Review

Abstract

Congenital dermatofibrosarcoma protuberans (DFSP) is an extremely rare skin tumor that is commonly misdiagnosed, or is often diagnosed long after the initial presentation. Although many cases of DFSP are diagnosed in adulthood, there are some differences between adult DFSP and congenital DFSP. We report a case of congenital DFSP that was initially misdiagnosed as a simple vascular lesion. The delay in diagnosis led to the considerable growth of the lesion, such that a huge scar was left after the surgical treatment. The major differences between adult and congenital DFSP are discussed through a literature review. Clinicians should be aware of the characteristics of congenital DFSP, to reduce misdiagnosis and the delay of diagnosis from the initial presentation.

INTRODUCTION

Congenital dermatofibrosarcoma protuberans (DFSP) is an extremely rare skin tumor that is commonly misdiagnosed, or is often diagnosed long after the initial presentation.

CASE REPORT

DFSP is a rare cutaneous tumor of fibrohistiocytic origin characterized by intermediate malignancy1. It is rare in children, and congenital cases are even more scarce23. Its diagnosis is also very difficult unless a biopsy is done.
An otherwise healthy 6-year-old girl was referred to our plastic and reconstructive unit by the dermatologic unit for the evaluation of an irregularly oval and indurated purplish plaque on the posterior neck. An area of the plaque showed a yellowish color (Fig. 1). It had been present like a bruise since birth and progressively became enlarged over time. This lesion was previously examined with punch biopsy by local dermatologists 2 years ago. It showed papillomatosis and slight hyperpigmentation of the basal layer of the epidermis; however, it did not present as a malignancy. At that time, the patient was treated with antihistamine pills and local steroid injection therapy; however, none of them helped improve her itchiness or intermittent pain.
The pathologic slide, made 2 years ago by a local dermatologist, was reviewed by our dermatology department. It showed histiocytes, and non-Langerhans cell histiocytosis needed to be ruled out. Typical pathologic findings for DFSP were not observed. For the pathologic confirmation, biopsy was again done by the dermatologic department. A specimen revealed dermal and subcutaneous infiltration of spindle cells within a myxoid stroma forming intersecting fascicles (Fig. 2). The immunohistochemical examination revealed a strong positivity for CD34 and vimentin, whereas S-100, smooth muscle actin, and factor XIIIa were negative, which were consistent with DFSP. Furthermore, no cytogenic abnormalities were found.
On physical examination, an about 2.0×2.0 cm irregular erythematous to violaceous plaque showing a focal atrophic hypopigmented scar tissue in the central portion was examined on the patient's posterior neck region. No evidences for metastasis were found.
Under general anesthesia, a wide excision with a safety margin of 3 cm was performed. The deep fascia and a portion of the muscle under the central part of the specimen were also included. The resulting defect was reconstructed with a bilobed transpositional fasciocutaneous flap from the interscapular area.
The histopathology confirmed DFSP with clear margins. There was no evidence of recurrence after 4 years (Fig. 3).

DISCUSSION

DFSP is a rare disease with an incidence of 0.08 per 100,0004. Especially, congenital DFSP is extremely rare23. The tumor is a slow-growing infiltrative dermal neoplasm with little metastatic potential. However, it shows a relatively high recurrence rate after surgical resection, and distant metastasis is rarely reported5. It is mostly seen during the early to mid-adult life6. Although a variety of diagnostic features have been recognized in the clinic, DFSP is difficult to diagnose when it presents as a simple plaque type without a nodule.
The patient in this case also had a bluish plaque on her posterior neck since birth; however, several local clinics considered the plaque to be a vascular lesion, and therefore no treatment was given. Therefore, the diagnosis as DFSP after a biopsy was delayed for 2 years. As a result of the delay, the DSFP became enlarged and a huge scar was left throughout her posterior neck through her back after the wide excision and transpositional fasciocutaneous flap coverage. It is unfortunate that she did not receive proper diagnosis and treatment at an earlier stage of the disease.
A review of the literature revealed that both congenital and adult DFSP can begin either as a small firm nodule or as a plaque-like lesion78. These lesions are freely movable in the underlying tissue and are usually fixed to the overlying skin. The color of the DFSP was brown to bluish-red, with a blue or red discoloration in the surrounding tissue. It is easily misdiagnosed as a vascular lesion because a bluish discoloration is often seen in the early stage of plaque-type DFSP8. As most congenital DFSPs become known in the early stage of the disease, it is essential for clinicians to be aware of the presentation during this period. The early-stage plaques are present in three different variants as follows: (i) an indurated flap plaque; (ii) a morphea-like, depressed sclerotic plaque; or (iii) an anetoderma-like depressed soft plaque3. This case is compatible with the second type. Thus, early-stage DFSP such as congenital DFSP tends to be misdiagnosed as a vascular lesion. Likewise, a differential diagnosis with morphea, atrophoderma, atrophic scar and lipoatrophy, keloid, and hypertrophic scar is needed910. This is why it is crucial for plastic and reconstructive surgeons, dermatologists, pediatricians, and family physicians to know well about the presentation of early-stage congenital DFSP.
On histopathological examination, DFSP shows typical sieve-like entrapment of fat cells infiltrating the subcutaneous tissue6711. The typical finding of DFSP consists of a storiform or whorled and moderately cellular pattern, and it is composed of atypical CD34-positive spindle cells. In the congenital type, the findings are mostly similar to the typical type but the cells are distributed more loosely so that the storiform pattern may not be seen, like in our case61213. Also, in this case, the first histopathologic finding showed only papillomatosis and slight hyperpigmentation of the basal layer of the epidermis without the storiform pattern, leading to a misdiagnosis. The immunohistochemistry of the spindle cells can be helpful for the differential diagnosis. The immunohistochemistry markers used for DFSP is CD34 for positivity and factor XIIIa and S-100 for negativity.
Advancement in diagnostic methods has allowed the identification of cytogenic abnormalities in DFSP. The most frequent abnormality is a supernumerary ring chromosome containing the sequences of chromosome 17 and 22. Furthermore, although less frequently, a reciprocal translocation, t(17;22)q(22;13), has also been described. However, these are mainly applicable to adult DFSP. According to the present report, the cytogenic abnormalities of chromosome 17 and 22 in the congenital type are not yet known314. It was also consistent with our result.
Thus, it is possible to determine the differences between adult DFSP and congenital DFSP through a review of the available literature. Those differences are summarized in Table 13678101112131415. Congenital DFSP is rare, and only a few cases have been reported. There is a possibility of delayed diagnosis in adulthood, as the disease is very difficult to diagnose in the early stage of plaque formation, especially in children. Early diagnosis is important to ensure an appropriate wide excision, to reduce the dimensions of the surgical scar, and to avoid the need for extensive surgery requiring reconstruction. To do this, specialized clinicians, such as plastic and reconstructive surgeons, dermatologists, pediatricians, and family physicians, who may have primary contact with the congenital DFSP, need to be aware of the features of the disease.

Figures and Tables

Fig. 1

An about 2.0×2.0 cm irregular erythematous-violaceous plaque showing an atrophic change with a scar tissue in the central portion on the posterior neck region. An area in the plaque shows a yellowish color.

ad-27-597-g001
Fig. 2

Typical spindle cells arranged in a storiform pattern infiltrating the dermis (H&E, ×400).

ad-27-597-g002
Fig. 3

Photograph at 4 years after surgery. The defect is covered with a bilobed transpositional fasciocutaneous flap.

ad-27-597-g003
Table 1

The differences between adult dermatofibrosarcoma protuberans (DFSP) and congenital DFSP through the literature review

ad-27-597-i001

References

1. Navarro M, Requena C, Febrer I, Marin S, Aliaga A. Dermatofibrosarcoma protuberans with onset in early childhood: a case report. J Eur Acad Dermatol Venereol. 2002; 16:154–155.
crossref
2. Reddy C, Hayward P, Thompson P, Kan A. Dermatofibrosarcoma protuberans in children. J Plast Reconstr Aesthet Surg. 2009; 62:819–823.
crossref
3. Jafarian F, McCuaig C, Kokta V, Laberge L, Ben Nejma B. Dermatofibrosarcoma protuberans in childhood and adolescence: report of eight patients. Pediatr Dermatol. 2008; 25:317–325.
crossref
4. Bendix-Hansen K, Myhre-Jensen O, Kaae S. Dermatofibrosarcoma protuberans. A clinico-pathological study of nineteen cases and review of world literature. Scand J Plast Reconstr Surg. 1983; 17:247–252.
crossref
5. Goldblum JR, Folpe AL, Weiss SW. Fibrohistiocytic tumors of intermediate malignancy. In : Goldblum JR, Folpe AL, Weiss SW, editors. Enzinger and Weiss's soft tissue tumors. 6th ed. St. Louis: CV Mosby;2014. p. 387–420.
6. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer. 1962; 15:717–725.
crossref
7. McPeak CJ, Cruz T, Nicastri AD. Dermatofibrosarcoma protuberans: an analysis of 86 cases--five with metastasis. Ann Surg. 1967; 166:803–816.
8. Burkhardt BR, Soule EH, Winkelmann RK, Ivins JC. Dermatofibrosarcoma protuberans. Study of fifty-six cases. Am J Surg. 1966; 111:638–644.
9. Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996; 35:355–374.
crossref
10. Weinstein JM, Drolet BA, Esterly NB, Rogers M, Bauer BS, Wagner AM, et al. Congenital dermatofibrosarcoma protuberans: variability in presentation. Arch Dermatol. 2003; 139:207–211.
11. Pack GT, Tabah EJ. Dermato-fibrosarcoma protuberans. A report of 39 cases. AMA Arch Surg. 1951; 62:391–411.
12. Cohen PR, Rapin RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa. Am J Dermatopathol. 1994; 16:573–574.
13. Prieto VG, Reed JA, Shea CR. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol. 1994; 21:324–329.
crossref
14. Rubin BP, Schuetze SM, Eary JF, Norwood TH, Mirza S, Conrad EU, et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol. 2002; 20:3586–3591.
crossref
15. Ballo MT, Zagars GK, Pisters P, Pollack A. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys. 1998; 40:823–827.
crossref
TOOLS
ORCID iDs

Young Min Park
https://orcid.org/http://orcid.org/0000-0002-3631-0807

Similar articles